Αρχική World News Olivia Newton-John Puts On Iconic ‘Grease’ Costume And Talks About Cancer Diagnosis

Olivia Newton-John Puts On Iconic ‘Grease’ Costume And Talks About Cancer Diagnosis

Photo: YouTube/CBS Sunday Morning and Paramount PicturesOlivia Newton-John was 28 years old when she slipped into an iconic Grease costume and became “Bad Sandy” in the 1978 hit movie. Now, at 71 years old, the outfit still fits her! She has slipped into the same outfit once again to show us just how svelte she’s stayed over the years.“They live again! They live again!” Newton-John exclaimed as she emerged in the leather pants and jacket. This occurred during her interview with Gayle King on CBS Sunday Morning. Prior to even putting on the pants, she revealed that she actually had to be stitched into the pants every time she put them on for the movie. Can you believe that?!
Olivia Newton-John’s iconic ‘Grease’ costumePhoto: YouTube/CBS Sunday Morning“I was a pretty skinny girl, and they were the perfect fit for me, except the zip was broken, so they would stitch me into them,” Newton-John revealed. She laughed while recalling that she would try her best not to need go to the bathroom while wearing those pants.This is one of the many costumes that the actress is planning to auction off for charity. A portion of the proceeds will be going towards her Olivia Newton-John Cancer Wellness and Research Center in Melbourne, Australia. She founded the wellness and research center during her own ongoing battle with breast cancer, which she is now fighting for the third time. She told Gayle that the pain can sometimes be “really bad.”
How she stays so positive amid cancer battlePhoto: Paramount Pictures“Crying pain, tears pain,” Newton-John explained. She also showed Gayle the marijuana plants she’s been growing to help combat that pain. She’s been very open about her use of medical cannabis during her cancer battle. Despite everything, she manages to keep a positive outlook on life. “In my opinion, if they give you a percentage, or you know, ‘This many women get this, and they live this long,’ you can create that and make it happen,” Newton-John explained. She believes not knowing how long she has left will help her live longer.“It’s almost like — I think I know what the statistics are, but I put them away. But I’m gonna live longer than that. I’ve made that decision. And I don’t buy into the statistics, because I think they can make you really nervous,” she said.
Photo: YouTube/CBS Sunday MorningNewton-John even went as far to joke that “denial is really healthy.” She elaborated, “It was consuming my day, and after some time I went, ‘You know what? I don’t know what my time is, but I need to enjoy my life, so I’m gonna eat a cookie if I want it, and I’m gonna have a cup of tea if I want it, and if I want to have a little bit of wine, then I’m gonna do that.’”Check out the full interview with Gayle King on CBS Sunday Morning below.Proper BCS greatergood_ctg_abovevideoSource

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...